8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Feb 24, 2026·SEC
DENTSPLY SIRONA Inc.(XRAY)Earnings, Financials & Key Ratios
XRAY•NASDAQ
Price updated Jun 19, 2026
AboutDENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.Show more
- Revenue$3.68B-3.0%
- EBITDA$604M+214.0%
- Net Income-$598M+34.3%
- EPS (Diluted)-3.00+33.0%
- Gross Margin50%-3.1%
- EBITDA Margin16.41%+217.5%
- Operating Margin6.85%+129.5%
- Net Margin-16.25%+32.3%
- ROE-36.43%-4.8%
XRAY Key Insights
DENTSPLY SIRONA Inc. (XRAY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Profits declining 52.3% over 5 years
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when XRAY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
XRAY Price & Volume
DENTSPLY SIRONA Inc. (XRAY) stock price & volume — 10-year historical chart
Loading chart...
XRAY Growth Metrics
DENTSPLY SIRONA Inc. (XRAY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years3.24%
5 Years1.96%
3 Years-2.1%
TTM-1.02%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM30.84%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM30.61%
Return on Capital
10 Years-3.41%
5 Years-3.6%
3 Years-4.22%
Last Year6.11%
XRAY Recent Earnings
DENTSPLY SIRONA Inc. (XRAY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (45%)●Beat Revenue 6/12 qtrs (55%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$0.27-3.6%
$0.28
Rev
$880M+4.5%
$842M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.27-3.6%
$0.28
Rev
$961M+3.8%
$926M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.37-17.8%
$0.45
Rev
$904M-2.5%
$927M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.52+4.0%
$0.50
Rev
$936M+3.5%
$905M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.27vs $0.28-3.6% | $880Mvs $842M+4.5% |
| Q1 2026 | Feb 26, 2026 | $0.27vs $0.28-3.6% | $961Mvs $926M+3.8% |
| Q4 2025 | Nov 6, 2025 | $0.37vs $0.45-17.8% | $904Mvs $927M-2.5% |
| Q3 2025 | Aug 7, 2025 | $0.52vs $0.50+4.0% | $936Mvs $905M+3.5% |
Based on last 12 quarters of dataView full earnings history →
XRAY Peer Comparison
DENTSPLY SIRONA Inc. (XRAY) competitors in Dental and vision care devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ALGN | 13.04B | 182.08 | 32.23 | 0.9% | 10.5% | 10.7% | 0.03 | |
 HSIC | 9.17B | 79.92 | 24.44 | 4.03% | 3.02% | 8.24% | 0.77 | |
 NVST | 4.22B | 25.91 | 92.54 | 8.32% | 2.41% | 2.18% | 0.55 | |
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 CNMD | 1B | 32.58 | 21.58 | 5.16% | 4% | 5.4% | 0.81 | |
 ATRC | 1.46B | 28.80 | -120 | 14.88% | -0.83% | -0.95% | 0.18 | |
 SYK | 117.88B | 307.80 | 36.64 | 11.16% | 12.92% | 15.04% | 0.66 |
Compare XRAY vs Peers
DENTSPLY SIRONA Inc. (XRAY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
XRAY Income Statement
DENTSPLY SIRONA Inc. (XRAY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 3.99B | 3.99B | 4.02B | 3.34B | 4.23B | 3.92B | 3.96B | 3.79B | 3.68B | 3.68B |
Revenue Growth % | 6.62% | -0.18% | 0.9% | -16.98% | 26.71% | -7.3% | 1.1% | -4.34% | -2.98% | -1.02% |
Cost of Goods Sold | 1.8B | 1.92B | 1.86B | 1.68B | 1.88B | 1.79B | 1.88B | 1.83B | 1.84B | 1.88B |
COGS % of Revenue | 45.2% | 48.13% | 46.2% | 50.4% | 44.53% | 45.77% | 47.39% | 48.38% | 50% | - |
Gross Profit | 2.19B▲ 0% | 2.07B▼ 5.5% | 2.16B▲ 4.7% | 1.66B▼ 23.5% | 2.35B▲ 41.7% | 2.13B▼ 9.4% | 2.09B▼ 1.9% | 1.96B▼ 6.1% | 1.84B▼ 6.0% | 1.8B▲ 0% |
Gross Margin % | 54.8% | 51.87% | 53.8% | 49.6% | 55.47% | 54.23% | 52.61% | 51.62% | 50% | 48.93% |
Gross Profit Growth % | 9.38% | -5.52% | 4.65% | -23.47% | 41.73% | -9.37% | -1.93% | -6.14% | -6.03% | - |
Operating Expenses | 1.67B | 1.72B | 1.81B | 1.66B | 1.74B | 3.06B | 2.17B | 2.84B | 1.59B | 1.58B |
OpEx % of Revenue | 41.94% | 43.13% | 45.03% | 49.69% | 41.1% | 78.12% | 54.75% | 74.8% | 43.15% | - |
Selling, General & Admin | 1.67B | 1.72B | 1.59B | 1.3B | 1.55B | 1.59B | 1.61B | 1.6B | 1.44B | 1.44B |
SG&A % of Revenue | 41.94% | 43.13% | 39.46% | 38.99% | 36.66% | 40.52% | 40.68% | 42.31% | 39.08% | - |
Research & Development | 151.7M | 160.5M | 143M | 123M | 171M | 174M | 184M | 165M | 150M | 158M |
R&D % of Revenue | 3.8% | 4.03% | 3.56% | 3.68% | 4.04% | 4.44% | 4.64% | 4.35% | 4.08% | - |
Other Operating Expenses | 2.07B | 1.33B | 81M | 234M | 17M | 1.3B | 374M | 1.07B | 0 | 0 |
Operating Income | -1.59B▲ 0% | -958.1M▲ 39.6% | 353M▲ 136.8% | -3M▼ 100.8% | 608M▲ 20366.7% | -937M▼ 254.1% | -85M▲ 90.9% | -879M▼ 934.1% | 252M▲ 128.7% | 151M▲ 0% |
Operating Margin % | -39.7% | -24.03% | 8.78% | -0.09% | 14.37% | -23.89% | -2.14% | -23.17% | 6.85% | 4.1% |
Operating Income Growth % | -448.65% | 39.56% | 136.84% | -100.85% | 20366.67% | -254.11% | 90.93% | -934.12% | 128.67% | - |
EBITDA | -1.27B | -627.3M | 676M | 331M | 954M | -609M | 258M | -530M | 604M | 424M |
EBITDA Margin % | -31.77% | -15.74% | 16.81% | 9.91% | 22.55% | -15.53% | 6.51% | -13.97% | 16.41% | 11.52% |
EBITDA Growth % | -274.68% | 50.56% | 207.76% | -51.04% | 188.22% | -163.84% | 142.36% | -305.43% | 213.96% | 182.17% |
D&A (Non-Cash Add-back) | 316.4M | 330.8M | 323M | 334M | 346M | 328M | 343M | 349M | 352M | 273M |
EBIT | -1.57B | -921M | 365M | -4M | 606M | -990M | -94M | -867M | -398M | -461M |
Net Interest Income | -35.9M | -35M | -27M | -61M | -61M | -65M | -81M | -69M | -88M | -66M |
Interest Income | 2.4M | 2.1M | 2.4M | 1M | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 38.3M | 37.3M | 29.4M | 62M | 61M | 65M | 81M | 69M | 88M | 90M |
Other Income/Expense | -41.2M | -400K | -15M | -47M | -63M | -118M | -90M | -57M | -738M | -723M |
Pretax Income | -1.63B▲ 0% | -958.4M▲ 41.1% | 338M▲ 135.3% | -50M▼ 114.8% | 545M▲ 1190.0% | -1.05B▼ 293.6% | -175M▲ 83.4% | -936M▼ 434.9% | -486M▲ 48.1% | -572M▲ 0% |
Pretax Margin % | -40.73% | -24.04% | 8.4% | -1.5% | 12.88% | -26.9% | -4.41% | -24.68% | -13.21% | -15.54% |
Income Tax | -53.2M | 52.5M | 82M | 23M | 134M | -105M | -43M | -26M | 112M | 55M |
Effective Tax Rate % | 3.27% | -5.48% | 24.26% | -46% | 24.59% | 9.95% | 24.57% | 2.78% | -23.05% | -9.62% |
Net Income | -1.55B▲ 0% | -1.01B▲ 34.8% | 256M▲ 125.3% | -73M▼ 128.5% | 411M▲ 663.0% | -950M▼ 331.1% | -132M▲ 86.1% | -910M▼ 589.4% | -598M▲ 34.3% | -628M▲ 0% |
Net Margin % | -38.81% | -25.36% | 6.37% | -2.19% | 9.71% | -24.22% | -3.33% | -23.99% | -16.25% | -17.06% |
Net Income Growth % | -460.55% | 34.77% | 125.32% | -128.52% | 663.01% | -331.14% | 86.11% | -589.39% | 34.29% | 30.84% |
Net Income (Continuing) | -1.55B | -1.01B | 256M | -73M | 411M | -950M | -132M | -910M | -598M | -627M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 11.6M | 11.9M | 2M | 3M | 1M | 1M | 1M | 1M | 1M | 0 |
EPS (Diluted) | -6.86▲ 0% | -4.51▲ 34.3% | 1.17▲ 125.9% | -0.38▼ 132.5% | 1.87▲ 592.1% | -4.41▼ 335.8% | -0.62▲ 85.9% | -4.48▼ 622.6% | -3.00▲ 33.0% | -3.14▲ 0% |
EPS Growth % | -453.61% | 34.26% | 125.94% | -132.48% | 592.11% | -335.83% | 85.94% | -622.58% | 33.04% | 30.61% |
EPS (Basic) | -6.86 | -4.51 | 1.18 | -0.38 | 1.88 | -4.41 | -0.62 | -4.48 | -3.00 | - |
Diluted Shares Outstanding | 229.4M | 224.3M | 224.4M | 219.2M | 220.2M | 215.5M | 212M | 203.2M | 199.4M | 199.9M |
Basic Shares Outstanding | 229.29M | 224.17M | 223.1M | 219.2M | 218.4M | 215.5M | 212M | 203.2M | 199.4M | 199.9M |
Dividend Payout Ratio | - | - | 31.64% | - | 22.38% | - | - | - | - | - |
XRAY Balance Sheet
DENTSPLY SIRONA Inc. (XRAY) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 2B | 1.89B | 2B | 1.8B | 1.85B | 1.89B | 1.97B | 1.75B | 2.02B | 1.84B |
Cash & Short-Term Investments | 320.6M | 309.6M | 405M | 438M | 339M | 365M | 334M | 272M | 326M | 190M |
Cash Only | 320.6M | 309.6M | 405M | 438M | 339M | 365M | 334M | 272M | 326M | 190M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 746.2M | 701.9M | 828M | 706M | 803M | 685M | 756M | 606M | 688M | 622M |
Days Sales Outstanding | 68.2 | 64.27 | 75.14 | 77.18 | 69.27 | 63.75 | 69.59 | 58.32 | 68.24 | 64.7 |
Inventory | 623.1M | 598.9M | 562M | 476M | 515M | 627M | 624M | 564M | 642M | 659M |
Days Inventory Outstanding | 126.01 | 113.94 | 110.4 | 103.23 | 99.77 | 127.5 | 121.21 | 112.19 | 127.35 | 129.21 |
Other Current Assets | 120.7M | 172.8M | 84M | 67M | 84M | 88M | 146M | 153M | 367M | 374M |
Total Non-Current Assets | 8.38B | 6.8B | 6.6B | 7.55B | 7.39B | 5.75B | 5.4B | 4.01B | 3.41B | 3.38B |
Property, Plant & Equipment | 876M | 870.6M | 961M | 967M | 971M | 961M | 978M | 902M | 1B | 997M |
Fixed Asset Turnover | 4.56x | 4.58x | 4.19x | 3.45x | 4.36x | 4.08x | 4.05x | 4.21x | 3.68x | 3.73x |
Goodwill | 4.52B | 3.43B | 3.4B | 3.99B | 3.98B | 2.69B | 2.44B | 1.6B | 1.15B | 1.14B |
Intangible Assets | 2.83B | 2.42B | 2.18B | 2.5B | 2.32B | 1.9B | 1.71B | 1.21B | 974M | 924M |
Long-Term Investments | -718M | -552.8M | 0 | 0 | 0 | 0 | 0 | 23M | 0 | 0 |
Other Non-Current Assets | 156.2M | 76.8M | 69M | 95M | 121M | 198M | 48M | 278M | 284M | 321M |
Total Assets | 10.38B▲ 0% | 8.69B▼ 16.3% | 8.6B▼ 1.0% | 9.35B▲ 8.7% | 9.24B▼ 1.2% | 7.64B▼ 17.3% | 7.37B▼ 3.6% | 5.75B▼ 21.9% | 5.43B▼ 5.6% | 5.23B▲ 0% |
Asset Turnover | 0.38x | 0.46x | 0.47x | 0.36x | 0.46x | 0.51x | 0.54x | 0.66x | 0.68x | 0.66x |
Asset Growth % | -10.95% | -16.31% | -0.97% | 8.68% | -1.19% | -17.27% | -3.57% | -21.94% | -5.63% | -45.89% |
Total Current Liabilities | 946.6M | 1.01B | 995M | 1.37B | 1.26B | 1.17B | 1.43B | 1.59B | 1.34B | 1.21B |
Accounts Payable | 284.4M | 283.9M | 308M | 302M | 262M | 279M | 305M | 241M | 300M | 259M |
Days Payables Outstanding | 57.51 | 54.01 | 60.51 | 65.5 | 50.76 | 56.73 | 59.25 | 47.94 | 59.51 | 53.15 |
Short-Term Debt | 30.1M | 92.4M | 2M | 299M | 182M | 118M | 322M | 549M | 360M | 230M |
Deferred Revenue (Current) | 8.9M | 29.3M | 29M | 53M | 68M | 84M | 91M | 95M | 74M | 271M |
Other Current Liabilities | 353.3M | 339.1M | 128M | 166M | 212M | 182M | 458M | 64M | 408M | 718M |
Current Ratio | 2.12x | 1.86x | 2.01x | 1.31x | 1.47x | 1.62x | 1.38x | 1.10x | 1.51x | 1.53x |
Quick Ratio | 1.46x | 1.27x | 1.45x | 0.96x | 1.06x | 1.08x | 0.95x | 0.74x | 1.03x | 0.98x |
Cash Conversion Cycle | 136.7 | 124.2 | 125.04 | 114.91 | 118.29 | 134.51 | 131.56 | 122.56 | 136.08 | 140.76 |
Total Non-Current Liabilities | 2.79B | 2.54B | 2.51B | 3.04B | 2.98B | 2.66B | 2.65B | 2.22B | 2.75B | 2.7B |
Long-Term Debt | 1.61B | 1.56B | 1.43B | 1.98B | 1.91B | 1.83B | 1.8B | 1.59B | 2.02B | 2.1B |
Capital Lease Obligations | 0 | 0 | 120M | 130M | 149M | 149M | 125M | 91M | 93M | 270M |
Deferred Tax Liabilities | 718M | 552.8M | 480M | 381M | 391M | 287M | 0 | 129M | 86M | 374M |
Other Non-Current Liabilities | 1.18B | 975.8M | 480M | 554M | 528M | 399M | 730M | 415M | 457M | 518M |
Total Liabilities | 3.74B | 3.55B | 3.51B | 4.42B | 4.24B | 3.83B | 4.08B | 3.81B | 4.09B | 3.91B |
Total Debt | 1.61B | 1.66B | 1.6B | 2.46B | 2.29B | 2.15B | 2.3B | 2.27B | 2.47B | 2.33B |
Net Debt | 1.29B | 1.35B | 1.19B | 2.02B | 1.96B | 1.78B | 1.97B | 2B | 2.14B | 2.14B |
Debt / Equity | 0.24x | 0.32x | 0.31x | 0.50x | 0.46x | 0.56x | 0.70x | 1.17x | 1.84x | 1.77x |
Debt / EBITDA | - | - | 2.37x | 7.42x | 2.40x | - | 8.91x | - | 4.09x | 5.50x |
Net Debt / EBITDA | - | - | 1.77x | 6.09x | 2.05x | - | 7.62x | - | 3.55x | 5.05x |
Interest Coverage | -40.93x | -24.69x | 12.41x | -0.06x | 9.93x | -15.23x | -1.16x | -12.57x | -4.52x | -5.12x |
Total Equity | 6.64B▲ 0% | 5.13B▼ 22.7% | 5.09B▼ 0.7% | 4.93B▼ 3.1% | 5B▲ 1.3% | 3.81B▼ 23.7% | 3.29B▼ 13.6% | 1.94B▼ 41.0% | 1.34B▼ 31.0% | 1.32B▲ 0% |
Equity Growth % | -18.27% | -22.71% | -0.74% | -3.14% | 1.26% | -23.71% | -13.59% | -41.01% | -31.03% | -142.05% |
Book Value per Share | 28.95 | 22.88 | 22.70 | 22.51 | 22.69 | 17.69 | 15.54 | 9.56 | 6.72 | 6.60 |
Total Shareholders' Equity | 6.63B | 5.12B | 5.09B | 4.93B | 5B | 3.81B | 3.29B | 1.94B | 1.34B | 1.32B |
Common Stock | 2.6M | 2.6M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M |
Retained Earnings | 2.32B | 1.23B | 1.4B | 1.2B | 1.51B | 456M | 205M | -835M | -1.56B | -1.57B |
Treasury Stock | -1.96B | -2.15B | -2.3B | -2.41B | -2.54B | -2.65B | -2.92B | -3.14B | -3.1B | 0 |
Accumulated OCI | -291M | -478.7M | -600M | -464M | -592M | -628M | -636M | -730M | -639M | -655M |
Minority Interest | 11.6M | 11.9M | 2M | 3M | 1M | 1M | 1M | 1M | 1M | 0 |
XRAY Cash Flow Statement
DENTSPLY SIRONA Inc. (XRAY) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 601.9M | 499.8M | 632.8M | 649M | 657M | 517M | 377M | 461M | 235M | 268M |
Operating CF Margin % | 15.07% | 12.54% | 15.73% | 19.44% | 15.53% | 13.18% | 9.51% | 12.15% | 6.39% | - |
Operating CF Growth % | 6.83% | -16.96% | 26.61% | 2.56% | 1.23% | -21.31% | -27.08% | 22.28% | -49.02% | 366.63% |
Net Income | -1.57B | -1.01B | 263.1M | -73M | 411M | -950M | -132M | -910M | -598M | -628M |
Depreciation & Amortization | 316.4M | 330.8M | 322.8M | 334M | 346M | 328M | 343M | 349M | 352M | 353M |
Stock-Based Compensation | 48M | 21M | 66.2M | 47M | 48M | 59M | 46M | 39M | 33M | 16M |
Deferred Taxes | -143.8M | -62M | -37.4M | -62M | -25M | -228M | -130M | -136M | 30M | -31M |
Other Non-Cash Items | 2.08B | 1.26B | 50M | 203M | 3M | 1.39B | 339M | 1.02B | 640M | 668M |
Working Capital Changes | -144.8M | -33.2M | -19.8M | 200M | -126M | -78M | -89M | 95M | -222M | -111M |
Change in Receivables | -63.4M | 23.5M | -91.4M | 131M | -117M | 85M | -58M | 104M | -91M | 0 |
Change in Inventory | -62.9M | -19.9M | 13.7M | 123M | -64M | -141M | 6M | 17M | -17M | -14M |
Change in Payables | 44.2M | 7.1M | 26.1M | -28M | -49M | 30M | 14M | -30M | 11M | -1M |
Cash from Investing | -286.4M | -253.3M | -68.4M | -1.11B | -358M | -138M | -89M | -197M | -132M | -168M |
Capital Expenditures | -151M | -188M | -122.9M | -87M | -142M | -149M | -149M | -180M | -131M | -164M |
CapEx % of Revenue | 3.78% | 4.72% | 3.06% | 2.61% | 3.36% | 3.8% | 3.76% | 4.75% | 3.56% | 4.46% |
Acquisitions | -145.9M | -130.5M | 8.4M | -1.08B | -220M | 0 | 13M | 0 | 0 | -1M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -144.5M | -179.3M | -117M | 1M | 2M | -2M | 47M | -17M | -1M | -4M |
Cash from Financing | -400.8M | -249.8M | -466.1M | 476M | -379M | -329M | -307M | -302M | -80M | -322M |
Debt Issued (Net) | -3.4M | 51M | -200.8M | 749M | -102M | -60M | 119M | 90M | 54M | -107M |
Equity Issued (Net) | -401.4M | -250M | -260M | -228M | -200M | -150M | -300M | -250M | 0 | 0 |
Dividends Paid | -78.3M | -78.6M | -80.9M | -88M | -92M | -104M | -116M | -126M | -128M | -128M |
Share Repurchases | -401.4M | -250M | -260M | -228M | -200M | -150M | -300M | -250M | 0 | 0 |
Other Financing | 82.3M | 27.8M | 75.6M | 43M | 15M | -15M | -10M | -16M | -6M | -87M |
Net Change in Cash | -63.3M▲ 0% | -11M▲ 82.6% | 95.3M▲ 966.4% | 33M▼ 65.4% | -99M▼ 400.0% | 26M▲ 126.3% | -31M▼ 219.2% | -62M▼ 100.0% | 54M▲ 187.1% | -208M▲ 0% |
Free Cash Flow | 450.9M▲ 0% | 311.8M▼ 30.8% | 509.9M▲ 63.5% | 562M▲ 10.2% | 515M▼ 8.4% | 368M▼ 28.5% | 228M▼ 38.0% | 281M▲ 23.2% | 104M▼ 63.0% | 104M▲ 0% |
FCF Margin % | 11.29% | 7.82% | 12.68% | 16.83% | 12.17% | 9.38% | 5.75% | 7.41% | 2.83% | 2.83% |
FCF Growth % | 3.11% | -30.85% | 63.53% | 10.22% | -8.36% | -28.54% | -38.04% | 23.25% | -62.99% | -62.59% |
FCF per Share | 1.97 | 1.39 | 2.27 | 2.56 | 2.34 | 1.71 | 1.08 | 1.38 | 0.52 | 0.52 |
FCF Conversion (FCF/Net Income) | -0.39x | -0.49x | 2.47x | -8.89x | 1.60x | -0.54x | -2.86x | -0.51x | -0.39x | -0.17x |
Interest Paid | 37M | 35M | 30M | 45M | 64M | 70M | 97M | 91M | 0 | 0 |
Taxes Paid | 122.7M | 105M | 112M | 82M | 148M | 122M | 177M | 74M | 0 | 0 |
XRAY Key Ratios
DENTSPLY SIRONA Inc. (XRAY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -20.99% | -17.17% | 5.01% | -1.46% | 8.28% | -21.57% | -3.72% | -34.75% | -36.43% | -41.19% |
Return on Invested Capital (ROIC) | -13.84% | -9.97% | 4.15% | -0.03% | 6.56% | -11.2% | -1.17% | -14.33% | 5.09% | 3.1% |
Gross Margin | 54.8% | 51.87% | 53.8% | 49.6% | 55.47% | 54.23% | 52.61% | 51.62% | 50% | 48.93% |
Net Margin | -38.81% | -25.36% | 6.37% | -2.19% | 9.71% | -24.22% | -3.33% | -23.99% | -16.25% | -17.06% |
Debt / Equity | 0.24x | 0.32x | 0.31x | 0.50x | 0.46x | 0.56x | 0.70x | 1.17x | 1.84x | 1.77x |
Interest Coverage | -40.93x | -24.69x | 12.41x | -0.06x | 9.93x | -15.23x | -1.16x | -12.57x | -4.52x | -5.12x |
FCF Conversion | -0.39x | -0.49x | 2.47x | -8.89x | 1.60x | -0.54x | -2.86x | -0.51x | -0.39x | -0.17x |
Revenue Growth | 6.62% | -0.18% | 0.9% | -16.98% | 26.71% | -7.3% | 1.1% | -4.34% | -2.98% | -1.02% |
Related:XRAY Dividend History·XRAY Revenue History·XRAY Price History·XRAY P/E History·XRAY Financial Ratios·XRAY Institutional Holders
XRAY SEC Filings & Documents
DENTSPLY SIRONA Inc. (XRAY) SEC filings — annual & quarterly reports (10-K, 10-Q)
XRAY Frequently Asked Questions
DENTSPLY SIRONA Inc. (XRAY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
DENTSPLY SIRONA Inc. (XRAY) reported $3.68B in revenue for fiscal year 2025. This represents a 461% increase from $656.6M in 1996.
DENTSPLY SIRONA Inc. (XRAY) saw revenue decline by 3.0% over the past year.
DENTSPLY SIRONA Inc. (XRAY) reported a net loss of $628.0M for fiscal year 2025.
Dividend & Returns
Yes, DENTSPLY SIRONA Inc. (XRAY) pays a dividend with a yield of 6.21%. This makes it attractive for income-focused investors.
DENTSPLY SIRONA Inc. (XRAY) has a return on equity (ROE) of -36.4%. Negative ROE indicates the company is unprofitable.
DENTSPLY SIRONA Inc. (XRAY) generated $104.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.